ProVise Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-936	Closed	-$270K	–	364
2022 Q4	$270K	Buy	936 +141	+18%	+$40.7K	0.03%	268
2022 Q3	$230K	Buy	+795	New	+$230K	0.03%	279